US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antibody Technologies Market Research Reports & Industry Analysis

RSS Feeds

Antibody Technologies Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
CD19 Therapeutics Market, 2016 - 2030
3/31/2016 | published by: Roots Analysis
... an immune response. Immunotherapies exploit the body's innate potential to specifically target a particular molecular antigen and mount an efficient immune response against the cells bearing the diseased signature. Currently, four major types of immunotherapies ...  |  read more...
USD 2,199
Global and Chinese Medical Biosensors Industry, 2016 Market Research Report
4/8/2016 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Medical Biosensors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides ...  |  read more...
USD 2,900
Fc Protein and Glycoengineered Antibodies Market (2nd Edition), 2016 - 2026
3/31/2016 | published by: Roots Analysis
... The Y-arm of the antibody is known as Fab, comprising a constant and a variable domain from each light and heavy chain. The variable domain (Fv) within the Fab region is responsible for target specificity ...  |  read more...
USD 2,199
Next-Generation Antibody Therapies Market Forecast 2016-2026
4/19/2016 | published by: Visiongain
... giving R&D trends, opportunities and sales forecasting. Discover in our study the most promising and lucrative parts of that industry. Our analysis lets you assess forecasted sales at overall world market, submarket, product and regional ...  |  read more...
USD 2,799
Global and Chinese Immunoadsorbent Column Industry, 2016 Market Research Report
4/11/2016 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Immunoadsorbent Column manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides ...  |  read more...
USD 2,900
Global Immunoglobulin Products Market 2016-2020
4/13/2016 | published by: TechNavio - Infiniti Research Ltd.
... amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for ...  |  read more...
USD 2,500
Immune Checkpoint Therapeutics - Hot Targets & Pipeline Analysis
4/26/2016 | published by: IQ4I Research and Consultancy
... in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins, Bi-specific Ab’s, Antibody drug conjugates, Cell therapy, Peptides, Oncolytic viruses and Vaccines. The report ...  |  read more...
USD 4,500
Monoclonal Antibody Markets in China
5/1/2016 | published by: Asia Market Information & Development Company
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ...  |  read more...
USD 4,000
Monoclonal Antibody Industry Forecasts - China Focus
5/1/2016 | published by: Asia Market Information & Development Company
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ...  |  read more...
USD 1,000
Biotechnology Products Industry Industry Forecasts - China Focus
5/1/2016 | published by: Asia Market Information & Development Company
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ...  |  read more...
USD 1,000
Monoclonal Antibody Companies in China
5/1/2016 | published by: Asia Market Information & Development Company
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ...  |  read more...
USD 1,800
Global Protein Therapeutics Industry 2016 Market Research Report
3/1/2016 | published by: 9Dimen Research
... the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Protein Therapeutics basic information including Protein Therapeutics definition, classification, ...  |  read more...
USD 2,850
Global Biotherapeutics Cell Line Development Industry 2016 Market Research Report
3/1/2016 | published by: 9Dimen Research
... (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Biotherapeutics Cell Line Development basics: definitions, classifications, applications and industry chain overview; industry policies and ...  |  read more...
USD 2,850
Global Anti-CD20 Monoclonal Antibodies Industry 2016 Market Research Report
3/18/2016 | published by: 9Dimen Research
... Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Anti-CD20 Monoclonal Antibodies basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; ...  |  read more...
USD 2,850
Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
3/1/2016 | published by: Current Partnering
... a detailed understanding and analysis of how and why companies enter Antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license ...  |  read more...
USD 2,995
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
3/1/2016 | published by: Current Partnering
... companies. Trends in cancer monoclonal antibody partnering deals Most active companies in cancer monoclonal antibody partnering Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal ...  |  read more...
USD 1,995
Antibodies in Oncology Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... the second wave in the lucrative field of therapeutic antibodies. There are today 527 companies plus partners developing 1187 antibody drugs in 2733 developmental projects in cancer. In addition, there are 5 suspended drugs and ...  |  read more...
USD 6,750
Anti-CD19 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD52 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10